共 99 条
[1]
Tan JA(2017)Mortality in ANCA associated vasculitis: a meta-analysis of observational studies Ann Rheum Dis 76 1566-1574
[2]
Dehghan N(2020)Comorbidities in ANCA-associated Vasculitis Rheumatology (Oxford) 63 588-596
[3]
Chen W(2011)A model to predict cardiovascular events in patients with newly diagnosed Wegener’s granulomatosis and microscopic polyangiitis Arthritis Care Res (Hoboken) 60 1187-1192
[4]
Xie H(2009)Increased morbidity from ischemic heart disease in patients with Wegener’s granulomatosis Arthritis Rheum 62 162-167
[5]
Esdaile JM(2003)Diffuse endothelial dysfunction is common to ANCA associated systemic vasculitis and polyarteritis nodosa Ann Rheum Dis 366 1059-1062
[6]
Avina-Zubieta JA(2005)The metabolic syndrome–a new worldwide definition Lancet 285 2486-2497
[7]
Kronbichler A(2001)Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) JAMA 52 197-203
[8]
Leierer J(2013)Metabolic syndrome in ANCA-associated vasculitis Rheumatology (Oxford) 96 134-141
[9]
Gauckler P(2019)Increased ischemic stroke, acute coronary artery disease and mortality in patients with granulomatosis with polyangiitis and microscopic polyangiitis J Autoimmun 25 177-184
[10]
Shin JI(2016)Metabolic syndrome is not only a risk factor for cardiovascular diseases in systemic lupus erythematosus but is also associated with cumulative organ damage: a cross-sectional analysis of 311 patients Lupus 26 32-38